Pts undergoing salvage esophagectomy after definitive chemoradiotherapy were evaluated for perdictors of survival. 5-year survival was 30%, which was related to tumor recurrence rather than residual tumor, complete resection, N status, M status, and dissection of more than 15 nodes. Additional neck dissection was not found to provide additional ben
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Esophagus
May 21, 2014
The PORTICO trial has opened to evaluate the Portico Transcatheter Aortic Valve System. This prospective multicenter trial involving up to 40 sites will randomize pts to Portico vs another TAVR valve in the US.
May 13, 2014
This video shows a left thoracotomy approach to a giant epiphrenic diverticulum in a symptomatic patient.
February 15, 2014
Pts surviving esophagectomy longer than 10 years were queried as to QOL. Alimentary comfort rating was 9 out of 10. 33% experienced diarrhea, dumping, or regurgitation. 15% had aspiration requiring hospital care. Mean weight loss was 26 lbs. Median GI QOL score was 2.9 out of 4.
February 10, 2014
The CROSS trials randomized pts with esophageal cancer or GEJ cancer to surgery vs induction chemoradiotherapy (CRT) followed by surgery. Prior studies reported a significant improvement in survival and freedom from recurrence associated with induction therapy.
December 4, 2013
This video demonstrates the treatment of esophageal squamous cell carcinomas through high intrathoracic circular anastomosis using a thoracoscopic technique.
November 14, 2012
For purposes of this survey, readers were asked to assume that they consulted on an otherwise healthy middle aged patient with a distal esophageal adenocarcinoma, T1bN0 by EUS. There were no contraindications to esophagectomy.
July 19, 2012
The Novalung Interventional Lung Assist (iLA) device is a membrane ventilator that allows for oxygen and carbon dioxide gas exchange to occur by simple diffusion.
July 17, 2012
For purposes of this survey, respondents were asked to assume they had recommended surgical therapy for a 63 year old man who had been diagnosed with a distal esophageal adenocarcinoma, clinically staged as T2N0 via EUS, CT, and PET. His general health was good. He had no prior abdominal or thoracic surgery, and he had no important comorbidities.